10-Q Filing

CELLDEX THERAPEUTICS, INC. CIK: 744218 Q1 2012

Filing Information

Form Type	10-Q
Accession Number	`0001104659-12-032960`
Period End Date	20120331
Filing Date	20120504
Fiscal Year	2012
Fiscal Period	Q1
XBRL Instance	cldx-20120331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 70 Income Statement 39 Cash Flow Statement 57

Balance Sheet 70 line items

Line Item	Tag	Value	Unit	Period
Convertible Preferred Stock, Par Value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Convertible Preferred Stock, Par Value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Convertible Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Convertible Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Convertible Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Convertible Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Convertible Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Convertible Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common Stock, Par Value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, Par Value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$11.90M	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$10.14M	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$22.75M	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$21.29M	USD	Point-in-time
Marketable Securities	`MarketableSecuritiesCurrent`	$41.41M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	297.00M	shares	Point-in-time
Marketable Securities	`MarketableSecuritiesCurrent`	$69.37M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	297.00M	shares	Point-in-time
Common Stock, Shares Issued	`CommonStockSharesIssued`	58.74M	shares	Point-in-time
Common Stock, Shares Issued	`CommonStockSharesIssued`	44.21M	shares	Point-in-time
Accounts and Other Receivables	`AccountsAndOtherReceivablesNetCurrent`	$170.00K	USD	Point-in-time
Accounts and Other Receivables	`AccountsAndOtherReceivablesNetCurrent`	$140.00K	USD	Point-in-time
Prepaid and Other Current Assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.97M	USD	Point-in-time
Prepaid and Other Current Assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.20M	USD	Point-in-time
Common Stock, Shares Outstanding	`CommonStockSharesOutstanding`	58.74M	shares	Point-in-time
Common Stock, Shares Outstanding	`CommonStockSharesOutstanding`	44.21M	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$94.24M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$54.68M	USD	Point-in-time
Property and Equipment, Net	`PropertyPlantAndEquipmentNet`	$9.09M	USD	Point-in-time
Property and Equipment, Net	`PropertyPlantAndEquipmentNet`	$8.45M	USD	Point-in-time
Intangible Assets, Net	`IntangibleAssetsNetExcludingGoodwill`	$24.92M	USD	Point-in-time
Intangible Assets, Net	`IntangibleAssetsNetExcludingGoodwill`	$24.63M	USD	Point-in-time
Other Assets	`OtherAssetsNoncurrent`	$329.00K	USD	Point-in-time
Other Assets	`OtherAssetsNoncurrent`	$460.00K	USD	Point-in-time
Goodwill	`Goodwill`	$8.96M	USD	Point-in-time
Goodwill	`Goodwill`	$8.96M	USD	Point-in-time
Total Assets	`Assets`	$136.74M	USD	Point-in-time
Total Assets	`Assets`	$97.99M	USD	Point-in-time
Accounts Payable	`AccountsPayableCurrent`	$535.00K	USD	Point-in-time
Accounts Payable	`AccountsPayableCurrent`	$935.00K	USD	Point-in-time
Accrued Expenses	`AccruedLiabilitiesCurrent`	$6.36M	USD	Point-in-time
Accrued Expenses	`AccruedLiabilitiesCurrent`	$7.01M	USD	Point-in-time
Current Portion of Long-Term Liabilities	`OtherLiabilitiesCurrent`	$219.00K	USD	Point-in-time
Current Portion of Long-Term Liabilities	`OtherLiabilitiesCurrent`	$358.00K	USD	Point-in-time
Current Portion of Term Loan	`SecuredDebtCurrent`	$5.29M	USD	Point-in-time
Current Portion of Term Loan	`SecuredDebtCurrent`	$6.14M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$12.55M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$14.30M	USD	Point-in-time
Term Loan, less Current Portion	`SecuredLongTermDebt`	$9.89M	USD	Point-in-time
Term Loan, less Current Portion	`SecuredLongTermDebt`	$9.01M	USD	Point-in-time
Other Long-Term Liabilities	`OtherLiabilitiesNoncurrent`	$6.42M	USD	Point-in-time
Other Long-Term Liabilities	`OtherLiabilitiesNoncurrent`	$5.97M	USD	Point-in-time
Total Liabilities	`Liabilities`	$29.27M	USD	Point-in-time
Total Liabilities	`Liabilities`	$28.85M	USD	Point-in-time
Commitments and Contingent Liabilities	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingent Liabilities	`CommitmentsAndContingencies`	-	USD	Point-in-time
Convertible Preferred Stock, $.01 Par Value; 3,000,000 Shares Authorized; No Shares Issued and Outstanding at March 31, 2012 and December 31, 2011	`PreferredStockValue`	-	USD	Point-in-time
Convertible Preferred Stock, $.01 Par Value; 3,000,000 Shares Authorized; No Shares Issued and Outstanding at March 31, 2012 and December 31, 2011	`PreferredStockValue`	-	USD	Point-in-time
Common Stock, $.001 Par Value; 297,000,000 Shares Authorized; 58,735,636 and 44,210,636 Shares Issued and Outstanding at March 31, 2012 and December 31, 2011, respectively	`CommonStockValue`	$59.00K	USD	Point-in-time
Common Stock, $.001 Par Value; 297,000,000 Shares Authorized; 58,735,636 and 44,210,636 Shares Issued and Outstanding at March 31, 2012 and December 31, 2011, respectively	`CommonStockValue`	$44.00K	USD	Point-in-time
Additional Paid-In Capital	`AdditionalPaidInCapitalCommonStock`	$271.03M	USD	Point-in-time
Additional Paid-In Capital	`AdditionalPaidInCapitalCommonStock`	$323.59M	USD	Point-in-time
Accumulated Other Comprehensive Income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$2.76M	USD	Point-in-time
Accumulated Other Comprehensive Income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$2.65M	USD	Point-in-time
Accumulated Deficit	`RetainedEarningsAccumulatedDeficit`	$-218.52M	USD	Point-in-time
Accumulated Deficit	`RetainedEarningsAccumulatedDeficit`	$-205.01M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$107.89M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$68.72M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$97.99M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$136.74M	USD	Point-in-time

Income Statement 39 line items

Line Item	Tag	Value	Unit	Period
Product Development and Licensing Agreements	`RevenueFromProductDevelopmentAndLicensingAgreements`	$14.00K	USD	1 Quarter
Product Development and Licensing Agreements	`RevenueFromProductDevelopmentAndLicensingAgreements`	$35.00K	USD	1 Quarter
Contracts and Grants	`RevenueFromContractsAndGrants`	$54.00K	USD	1 Quarter
Product Royalties	`RoyaltyRevenue`	$2.34M	USD	1 Quarter
Product Royalties	`RoyaltyRevenue`	$2.50M	USD	1 Quarter
Total Revenue	`Revenues`	$2.43M	USD	1 Quarter
Total Revenue	`Revenues`	$2.52M	USD	1 Quarter
Research and Development	`ResearchAndDevelopmentExpense`	$6.85M	USD	1 Quarter
Research and Development	`ResearchAndDevelopmentExpense`	$10.77M	USD	1 Quarter
Royalty	`RoyaltyExpense`	$2.50M	USD	1 Quarter
Royalty	`RoyaltyExpense`	$2.34M	USD	1 Quarter
General and Administrative	`GeneralAndAdministrativeExpense`	$2.34M	USD	1 Quarter
General and Administrative	`GeneralAndAdministrativeExpense`	$2.32M	USD	1 Quarter
Amortization of Acquired Intangible Assets	`AmortizationOfIntangibleAssets`	$291.00K	USD	1 Quarter
Amortization of Acquired Intangible Assets	`AmortizationOfIntangibleAssets`	$483.00K	USD	1 Quarter
Total Operating Expense	`CostsAndExpenses`	$12.17M	USD	1 Quarter
Total Operating Expense	`CostsAndExpenses`	$15.72M	USD	1 Quarter
Operating Loss	`OperatingIncomeLoss`	$-9.66M	USD	1 Quarter
Operating Loss	`OperatingIncomeLoss`	$-13.29M	USD	1 Quarter
Investment and Other Income, Net	`NonoperatingIncomeExpense`	$84.00K	USD	1 Quarter
Investment and Other Income, Net	`NonoperatingIncomeExpense`	$205.00K	USD	1 Quarter
Interest Expense	`InterestExpense`	$485.00K	USD	1 Quarter
Interest Expense	`InterestExpense`	$433.00K	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-13.52M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-10.06M	USD	1 Quarter
Basic and Diluted Net Loss Per Common Share (Note 3) (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.27	USD	1 Quarter
Basic and Diluted Net Loss Per Common Share (Note 3) (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.31	USD	1 Quarter
Shares Used in Calculating Basic Net Loss per Share (Note 3) (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	32.05M	shares	1 Quarter
Shares Used in Calculating Basic Net Loss per Share (Note 3) (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	50.15M	shares	1 Quarter
Shares Used in Calculating Diluted Net Loss per Share (Note 3) (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	50.15M	shares	1 Quarter
Shares Used in Calculating Diluted Net Loss per Share (Note 3) (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	32.05M	shares	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-13.52M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-10.06M	USD	1 Quarter
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$2.00K	USD	1 Quarter
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-4.00K	USD	1 Quarter
Unrealized Gain on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$13.00K	USD	1 Quarter
Unrealized Gain on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$108.00K	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-10.05M	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-13.41M	USD	1 Quarter

Cash Flow Statement 57 line items

Line Item	Tag	Value	Unit	Period
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-13.52M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-10.06M	USD	1 Quarter
Depreciation and Amortization	`DepreciationDepletionAndAmortization`	$562.00K	USD	1 Quarter
Depreciation and Amortization	`DepreciationDepletionAndAmortization`	$544.00K	USD	1 Quarter
Amortization of Intangible Assets	`AmortizationOfIntangibleAssets`	$291.00K	USD	1 Quarter
Amortization of Intangible Assets	`AmortizationOfIntangibleAssets`	$483.00K	USD	1 Quarter
Amortization and Premium of Marketable Securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-244.00K	USD	1 Quarter
Amortization and Premium of Marketable Securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$373.00K	USD	1 Quarter
Realized (Gain) Loss on Sales and Maturities of Marketable Securities	`MarketableSecuritiesGainLoss`	$4.00K	USD	1 Quarter
Realized (Gain) Loss on Sales and Maturities of Marketable Securities	`MarketableSecuritiesGainLoss`	$-5.00K	USD	1 Quarter
Loss (Gain) on Sales or Disposal of Assets	`GainLossOnSaleOfPropertyPlantEquipment`	$-23.00K	USD	1 Quarter
Loss (Gain) on Sales or Disposal of Assets	`GainLossOnSaleOfPropertyPlantEquipment`	$55.00K	USD	1 Quarter
Stock-Based Compensation Expense	`ShareBasedCompensation`	$580.00K	USD	1 Quarter
Stock-Based Compensation Expense	`ShareBasedCompensation`	$641.00K	USD	1 Quarter
Non-Cash Interest Expense	`AmortizationOfDebtDiscountPremium`	$57.00K	USD	1 Quarter
Non-Cash Interest Expense	`AmortizationOfDebtDiscountPremium`	$135.00K	USD	1 Quarter
Accounts and Other Receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-81.00K	USD	1 Quarter
Accounts and Other Receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-30.00K	USD	1 Quarter
Prepaid and Other Current Assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$162.00K	USD	1 Quarter
Prepaid and Other Current Assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$672.00K	USD	1 Quarter
Other Assets	`IncreaseDecreaseInOtherOperatingAssets`	$37.00K	USD	1 Quarter
Other Assets	`IncreaseDecreaseInOtherOperatingAssets`	$131.00K	USD	1 Quarter
Accounts Payable and Accrued Expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-1.05M	USD	1 Quarter
Accounts Payable and Accrued Expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-929.00K	USD	1 Quarter
Other Liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$288.00K	USD	1 Quarter
Other Liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$606.00K	USD	1 Quarter
Net Cash Used in Operating Activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-8.86M	USD	1 Quarter
Net Cash Used in Operating Activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-13.55M	USD	1 Quarter
Sales and Maturities of Marketable Securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$8.65M	USD	1 Quarter
Sales and Maturities of Marketable Securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$5.91M	USD	1 Quarter
Purchases of Marketable Securities	`PaymentsToAcquireMarketableSecurities`	$3.25M	USD	1 Quarter
Purchases of Marketable Securities	`PaymentsToAcquireMarketableSecurities`	$33.39M	USD	1 Quarter
Acquisition of Property and Equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$202.00K	USD	1 Quarter
Acquisition of Property and Equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$42.00K	USD	1 Quarter
Proceeds from Sales or Disposal of Assets	`ProceedsFromSaleOfProductiveAssets`	$11.00K	USD	1 Quarter
Proceeds from Sales or Disposal of Assets	`ProceedsFromSaleOfProductiveAssets`	$64.00K	USD	1 Quarter
Net Cash (Used in) Provided by Investing Activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$5.27M	USD	1 Quarter
Net Cash (Used in) Provided by Investing Activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-27.51M	USD	1 Quarter
Net Proceeds from Stock Issuances	`ProceedsFromIssuanceOfCommonStock`	$51.93M	USD	1 Quarter
Issuance of Term Loan	`ProceedsFromIssuanceOfLongTermDebt`	$5.00M	USD	1 Quarter
Payment of Convertible Subordinated Debt	`RepaymentsOfConvertibleDebt`	$12.50M	USD	1 Quarter
Payments of Other Liabilities	`RepaymentsOfOtherLongTermDebt`	$46.00K	USD	1 Quarter
Payments of Other Liabilities	`RepaymentsOfOtherLongTermDebt`	$15.00K	USD	1 Quarter
Net Cash Provided by (Used in) Financing Activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-7.55M	USD	1 Quarter
Net Cash Provided by (Used in) Financing Activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$51.91M	USD	1 Quarter
Effect of Exchange Rate Changes on Cash and Cash Equivalents	`EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations`	$-4.00K	USD	1 Quarter
Effect of Exchange Rate Changes on Cash and Cash Equivalents	`EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations`	$2.00K	USD	1 Quarter
Net Increase (Decrease) in Cash and Cash Equivalents	`NetCashProvidedByUsedInContinuingOperations`	$10.86M	USD	1 Quarter
Net Increase (Decrease) in Cash and Cash Equivalents	`NetCashProvidedByUsedInContinuingOperations`	$-11.15M	USD	1 Quarter
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$11.90M	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$10.14M	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$22.75M	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$21.29M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$11.90M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$10.14M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$22.75M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$21.29M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.